Ιt is noteworthy that Interleukin (IL)-6, the founding member of myokines, acts in a pleiotropic manner regarding cancer evolution, since different origins and signaling pathways have been associated with either its anti- or pro-tumorigenic properties [52]. This evidence concerns the gene IL6 and cancer.